Rhythm Biosciences appoints Gavin Fox-Smith as Chair

November 5, 2025 Australian Biotech BioPharmaDispatch Executive

This is a preview of subscriber content

Subscribe now to continue reading.

Australian cancer diagnostics company Rhythm Biosciences (ASX:RHY) has appointed Gavin Fox-Smith as its new Chair, following the retirement of Otto Buttula at the company’s Annual General Meeting. …

Subscribe now to continue reading.

Latest Video

Sanofi leader urges Australia to look beyond the laboratory in building vaccine capability
August 31, 2026 - Latest News
Those who ask questions and critique the process are treated as people who question and critique the process
September 1, 2026 - Latest News
Roche maps a new chapter with move to new Sydney CBD location
September 2, 2026 - Latest News
Astellas Australia turns to rare disease leader Guillaume Pfeiffer for next chapter
August 31, 2026
Funding brings a new targeted treatment for Australians with lupus kidney disease
August 31, 2026 - Latest News

Rhythm Biosciences appoints Gavin Fox-Smith as Chair

This is a preview of subscriber content

Latest Video

Most Read

Sanofi leader urges Australia to look beyond the laboratory in building vaccine capability

Those who ask questions and critique the process are treated as people who question and critique the process

Roche maps a new chapter with move to new Sydney CBD location

Astellas Australia turns to rare disease leader Guillaume Pfeiffer for next chapter

Funding brings a new targeted treatment for Australians with lupus kidney disease

New Stories

BMS therapy secures Australian approval for psoriatic arthritis

The live lesson from the UK on who holds the levers and how they use them

Gilead returns to Medicines Australia as industry prepares to make the case for innovation

Combined monitoring of key indicators as the future of diabetes care

ENA Respiratory secures funding to test antiviral nasal spray in people with asthma

OncoSil pursues a reimbursement pathway as it prepares for US rollout

Vitrafy takes its cryopreservation technology into the US cell therapy market

Sign In

Rhythm Biosciences appoints Gavin Fox-Smith as Chair

This is a preview of subscriber content

Latest Video

Most Read

Sanofi leader urges Australia to look beyond the laboratory in building vaccine capability

Those who ask questions and critique the process are treated as people who question and critique the process

Roche maps a new chapter with move to new Sydney CBD location

Astellas Australia turns to rare disease leader Guillaume Pfeiffer for next chapter

Funding brings a new targeted treatment for Australians with lupus kidney disease

Follow Us

New Stories

BMS therapy secures Australian approval for psoriatic arthritis

The live lesson from the UK on who holds the levers and how they use them

Gilead returns to Medicines Australia as industry prepares to make the case for innovation

Combined monitoring of key indicators as the future of diabetes care

ENA Respiratory secures funding to test antiviral nasal spray in people with asthma

OncoSil pursues a reimbursement pathway as it prepares for US rollout

Vitrafy takes its cryopreservation technology into the US cell therapy market